8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Effect of hydrophilic polymers on the wettability, static and dynamic, of solid substrate covered by confluent monolayer of air-damaged SIRC cells

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The aim of this study was to evaluate the possible implementation of hydrophilic polymers as recovery agents in air-damaged corneal cells. The sessile bubble technique was implemented to measure the wetting properties of four selected polymers: hydroxyethyl cellulose (HEC), sodium chondroitin sulphate (SCS), hydroxypropyl-methylcellulose (HPMC) and poloxamer F127 (PO12), at equilibrium conditions and in the case of advancing and receding contact angle. For testing the wetting properties of the polymers, glass slides covered with a confluent monolayer of Statens Seruminstitut rabbit cornea (SIRC) cells were used. HEC showed best properties for a broad concentration range, as the polymer showed capability to maintain low values of the static (equilibrium) contact angle (average static contact angle – 36.07˚, compared to average static compact angles of HPMC – 38.44˚, PO12 – 38.92˚ and SCS – 37.85˚), i.e. better wettability. Sessile bubble technique provides quick, relatively simple and reliable approach for testing surface properties of the listed polymers. The nature of the surface damage produced by the exposition of SIRC cells was used as a plausible model of evaporative dry eye syndrome, and thus the results may have clinical implementation.

          Related collections

          Most cited references 7

          • Record: found
          • Abstract: found
          • Article: not found

          Challenges and obstacles of ocular pharmacokinetics and drug delivery.

           Arto Urtti (2006)
          Modern biological research has produced increasing number of promising therapeutic possibilities for medical treatment. These include for example growth factors, monoclonal antibodies, gene knockdown methods, gene therapy, surgical transplantations and tissue engineering. Ocular application of these possibilities involves drug delivery in many forms. Ocular drug delivery is hampered by the barriers protecting the eye. This review presents an overview of the essential factors in ocular pharmacokinetics and selected pharmacological future challenges in ophthalmology.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Effects of ocular surface area and blink rate on tear dynamics.

            To study the effects of exposed ocular surface area and blink rate on tear dynamics by the measurement of tear evaporation under a range of conditions. Tear evaporation was measured in three gaze positions in 15 normal volunteers, and the ocular surface area was determined as a function of the width of the palpebral fissure. In 17 normal volunteers, the effect of blink rate on tear evaporation was assessed. The ocular surface area was 1.2 +/- 0.27, 2.2 +/- 0.39, and 3.0 +/- 0.33 cm2 with patients looking down, ahead, and up, respectively. The corresponding tear evaporation rates per eye were 7.0 +/- 3.5, 17.6 +/- 6.6, and 23.7 +/- 6.3 x 10(-7) g/s, respectively. The tear evaporation per square meter also increased proportionally with the ocular surface area. When the blink rate was changed from 10 to 60 per minute, the tear evaporation did not change in those individuals with evaporation rates more than 7.8 x 10(-7) g/s per square centimeter, whereas it did increase with the blink rate in those whose evaporation rates were lower. Ocular surface area and blink rate affect tear dynamics. Moderate palpebral fissure width and blink rate are necessary for the prevention of desiccation of the ocular surface.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              The definition and classification of dry eye disease: Report of the definition and classification subcommittee of the International Dry Eye WorkShop (2007)

                Bookmark

                Author and article information

                Journal
                Biotechnol Biotechnol Equip
                Biotechnol. Biotechnol. Equip
                TBEQ
                tbeq20
                Biotechnology, Biotechnological Equipment
                Taylor & Francis
                1310-2818
                1314-3530
                4 March 2015
                13 January 2015
                : 29
                : 2
                : 390-394
                Affiliations
                [ a ]Department of Biochemistry, Faculty of Biology, Sofia University ‘St. Kliment Ohridski’ , Sofia, Bulgaria
                [ b ]Department of Cytology, Histology and Embriology, Faculty of Biology, Sofia University ‘St. Kliment Ohridski’ , Sofia, Bulgaria
                Author notes
                [* ]Corresponding author. Email: ggeorg@ 123456biofac.uni-sofia.bg
                Article
                997541
                10.1080/13102818.2014.997541
                4433808
                26019657
                © 2015 The Author(s). Published by Taylor & Francis.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                Page count
                Figures: 5, Tables: 2, References: 10, Pages: 5
                Product
                Funding
                Funded by: Rohto Pharmaceutical Co.
                Award ID: 1970
                The study was supported by a Collaborative Study [grant number 1970] by Rohto Pharmaceutical Co., Osaka, Japan.
                Categories
                Articles; Pharmaceutical Biotechnology

                Comments

                Comment on this article